business
BioHarvest Sciences Q1 Earnings Call Highlights
Key takeaways
- Bio Harvest Sciences Q1 Earnings Call Highlights Market Beat Thu, May 14, 2026 at 9:07 PM GMT+7 7 min read BHST Key Points Interested in Bio Harvest Sciences Inc.?
- Bio Harvest Sciences reported first-quarter revenue of $8.5 million, up 8% year over year, and kept its 2026 guidance unchanged for both the D2C and CDMO businesses.
- The company is reorganizing around a two-business structure: the VINIA direct-to-consumer segment and the CDMO platform.
Bio Harvest Sciences Q1 Earnings Call Highlights Market Beat Thu, May 14, 2026 at 9:07 PM GMT+7 7 min read BHST Key Points Interested in Bio Harvest Sciences Inc.? Here are five stocks we like better.
Bio Harvest Sciences reported first-quarter revenue of $8.5 million, up 8% year over year, and kept its 2026 guidance unchanged for both the D2C and CDMO businesses. Cash and deposits rose sharply to $20.2 million from $3.4 million a year earlier.
The company is reorganizing around a two-business structure: the VINIA direct-to-consumer segment and the CDMO platform. Management said this should improve capital allocation and execution, while also preparing for a new manufacturing facility expected to begin production in 2H 2027.
Article preview — originally published by Yahoo Finance. Full story at the source.
Read full story on Yahoo Finance →
More top stories
Also covered by
Investing.com
Earnings call transcript: Caris Life Sciences Q1 2026 sees robust growth but stock dips
Investing.com
Earnings call transcript: Cellebrite Q1 2026 earnings beat estimates
Investing.com
Earnings call transcript: WhiteFiber Q1 2026 sees significant EPS miss
Investing.com
Earnings call transcript: CSN Mineração Q1 2026 shows mixed results
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop